GSK-3 inhibitor 9-ING-41, Purity ≥98%

Synonym: 1034895-42-5; 9-ING-41; Elraglusib; 3-(5-Fluorobenzofuran-3-yl)-4-(5-methyl-5H-[1,3]dioxolo[4,5-f]indol-7-yl)-1H-pyrrole-2,5-dione; Elraglusib [USAN]; GSK-3 inhibitor

CAS Number: 1034895-42-5
Compound CID: 44582816

Product Size

5 mg; 10 mg; 50 mg; 100 mg

Price

Datasheet

Datasheet

MSDS

MSDS

Properties

Description

9-ING-41 modulates various cellular processes, including glucose metabolism, inflammation, and cell proliferation, with potential applications in treating diseases like diabetes and neurodegenerative disorders.

Molecular Weight

404.35

Molecular Formula

C₂₂H₁₃FN₂O₅

Form

Lyophilized powder

Purity

≥98%

Identity

Confirmed by NMR/HPLC/MS.

Stability

The product is stable for three years when stored at the recommended temperature in lyophilized powder.

Applications

9-ING-41 is employed in studying its inhibitory effects on GSK-3β for cancer treatments.

Storage

Store at -20ºC.